Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome associated with high-dose interleukin-2 for the treatment of metastatic melanoma.
about
Antineoplastic agents and thrombotic microangiopathy.Modeling the receptor pharmacology, pharmacokinetics, and pharmacodynamics of NKTR-214, a kinetically-controlled interleukin-2 (IL2) receptor agonist for cancer immunotherapy.Hemolytic uremic syndrome and E. coli infection in cancerous patients: A topic to be discussed in oncology.Cancerous patients and outbreak of Escherichia coli: an important issue in oncology
P2860
Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome associated with high-dose interleukin-2 for the treatment of metastatic melanoma.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Thrombotic thrombocytopenic pu ...... atment of metastatic melanoma.
@ast
Thrombotic thrombocytopenic pu ...... atment of metastatic melanoma.
@en
type
label
Thrombotic thrombocytopenic pu ...... atment of metastatic melanoma.
@ast
Thrombotic thrombocytopenic pu ...... atment of metastatic melanoma.
@en
prefLabel
Thrombotic thrombocytopenic pu ...... atment of metastatic melanoma.
@ast
Thrombotic thrombocytopenic pu ...... atment of metastatic melanoma.
@en
P2093
P1476
Thrombotic thrombocytopenic pu ...... atment of metastatic melanoma.
@en
P2093
Doru T Alexandrescu
Janice P Dutcher
Peter H Wiernik
Prasad Maddukuri
P304
P356
10.1097/01.CJI.0000154250.82007.4A
P577
2005-03-01T00:00:00Z